76 |
N00076 |
RB-AuNP |
Acetylcholinesterase (AChE) |
Transgenic mice |
|
77 |
N00077 |
Fe@AuNPs |
Acetylcholinesterase (AChE) |
|
|
78 |
N00078 |
AC-HAp-NPs |
Acetylcholinesterase (AChE) |
This study sought to identify phytoconstituents that might bind to the crucial AD amyloid hypothesis targets while also testing the ability of the synthesized AC-HAp NPs to inhibit AChE |
|
79 |
N00079 |
AC-HAp-NPs |
Butyrylcholinesterase (BChE) |
This study sought to identify phytoconstituents that might bind to the crucial AD amyloid hypothesis targets while also testing the ability of the synthesized AC-HAp NPs to inhibit AChE |
|
80 |
N00080 |
AChE inhibition- fullerene (C60) derivatives as new drugs a |
Acetylcholinesterase (AChE) |
Molecular dynamics simulations |
|
81 |
N00081 |
AChE inhibition- fullerene (C60) derivatives as new drugs a |
Butyrylcholinesterase (BChE) |
Molecular dynamics simulations |
|
82 |
N00082 |
AChE inhibition- fullerene (C60) derivatives as new drugs a |
Aβ25-35 |
Molecular dynamics simulations |
|
83 |
N00083 |
3.3 nm L- and D-glutathione stabilized gold nanoparticles |
Aβ |
A mouse model of Alzheimer's disease |
|
84 |
N00084 |
poly (D,L-lactic acid-co-glycolic acid) (PLGA) |
Aβ |
5XFAD mice |
|
85 |
N00085 |
Quercetin lipid nanoparticles functionalized with transferrin |
Aβ |
HCMEC/D3 cell line |
|
86 |
N00086 |
11-mercapto-1-undecanesulfonate-coated gold nanoparticles (NPs) |
Aβ |
In vitro neuronal cell models |
|
87 |
N00087 |
Ultrasmall copper sulfide nanoparticle-engineered covalent organic framework hybrid nanocomposites (CuS@COFs) , electroactive thionine (Thi) and Aβ antibody-modified gold nanoparticles (Thi-AuNPs-Ab bioconjugates) |
Aβ |
|
|
88 |
N00088 |
A High-Quality CdSe/CdS/ZnS Quantum-Dot-Based FRET Aptasensor |
Amyloid-β oligomers (AβO) |
By monitoring the change in the fluorescence signals of the QDs-DNA under single-wavelength excitation |
|
89 |
N00089 |
AC-HAp NPs |
Anti-acetylcholinesterase (AChE) |
Acorus Calamus Plant Extract |
|
90 |
N00090 |
CUR-encapsulated chitosan-coated poly (lactic-co-glycolic acid) nanoparticles (CUR-CS-PLGA-NPs) and hydroxypropyl-β-cyclodextrin-encapsulated CUR complexes (CUR/HP-β-CD |
Aβ |
SH-SY5Y cells |
|
91 |
N00091 |
KLVFF peptide-NPs(NPs) |
Aβ |
Alzheimer disease (AD) |
|
92 |
N00092 |
Ga-terminated dendrimers |
Aβ |
SH-SY5Y cells;MD |
|
93 |
N00093 |
HQ NPs |
Aβ |
PC12 cells;C57BL/6 and APP/PS1 mice |
|
94 |
N00094 |
Lf-PPN |
Aβ |
The porcine brain capillary endothelial cells (PBCECs) and C6 glioma cells |
|
95 |
N00095 |
Solid Lipid Nanoparticles (SLNs) |
Aβ |
Drug Delivery System |
|
96 |
N00096 |
T807/TPP-RBC-NPs |
Aβ |
BMECs;ICR mice;HT22 and RAW 264.7 cells |
|
97 |
N00097 |
α-mangostin (αM) -loaded poly(ethylene glycol) -poly(l-lactide) (PEG-PLA) nanoparticles (NP-αM) |
Aβ |
Immortalized mouse brain endothelial cell line b.End3 and immortalized mouse microglial cell line BV-2 |
|
98 |
N00098 |
CGA@SeNPs |
Aβ |
PC12 cells |
|
99 |
N00099 |
AgNP |
Aβ |
BV-2 mouse microglial cells |
|
100 |
N00100 |
ALNs with curcumin |
Aβ |
|
|